Tambo, Inc.

San Francisco, CA

UEI
KJ8KQCTJBL17
CAGE
7BST8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
665 3rd St #250, San Francisco, CA 94107, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the click activated… R44TR004026 National Center for Advancing Translational Sciences (NIH) $2,139,478
Generalizable protodrug characteristics for in vivo drug release using the click activated protodrugs (cap) platform R43TR004026 National Center for Advancing Translational Sciences (NIH) $600,448
Material-guided delivery and local activation of bioorthogonal prodrugs R44GM130240 National Institute of General Medical Sciences (NIH) $2,824,998
Material guided drug delivery for pigmented villonodular synovitis using an implantable biomaterial and… R43CA224561 National Cancer Institute (NIH) $245,207
Material guided drug delivery for pediatric tumors using an implantable biomaterial and BIO-orthogonal chemistry R43HD093495 National Institute of Child Health and Human Development (NIH) $299,877

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Tambo, Inc. registered in SAM.gov?

Yes. Tambo, Inc.'s SAM.gov registration is active through April 20, 2027.

What is Tambo, Inc.'s most recent federal award?

Tambo, Inc.'s most recent federal grant award is Discovery of solubilizing side chains for in vivo release of diverse drug classes using the click activated… (R44TR004026), from National Center for Advancing Translational Sciences (NIH), on August 17, 2022.

On GovTribe

See Tambo, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login